Key result
Chronic intermittent hypobaric hypoxia markedly enhances rat carotid sinus baroreflex partly via K ATP channels.
Why the study?
Does chronic intermittent hypobaric hypoxia facilitate carotid sinus baroreflex in anesthetized rats?
Does chronic intermittent hypobaric hypoxia facilitate carotid sinus baroreflex in anesthetized rats?
Chronic intermittent hypobaric hypoxia facilitates carotid sinus baroreflex through opening K ATP channels, which may help maintain systemic arterial blood pressure homeostasis during acute hypoxia.
Hypothesis-generating for K ATP-mediated baroreflex enhancement by intermittent hypoxia in rats; leaves open human translation.
Our previous study showed that chronic intermittent hypobaric hypoxia (CIHH) could prevent decreases in systemic arterial blood pressure (SABP) during acute hypoxia. However, the mechanism was not clear. The purpose of the present study was to observe whether the carotid sinus baroreflex (CSB) was involved in the antagonizing effect of CIHH on SABP decrease induced by acute hypoxia and to explore the underlying mechanism using perfusion technique in rat isolated carotid sinus area. After 14-day and 28-day CIHH exposure, the CSB in rats was enhanced markedly, manifesting as increases in PS and RD, and decreases in TP and SP. This facilitation of CSB was partly abolished by Glibenclamide (Gli, 10 μM), a K ATP channel blocker, but was not influenced by L-NAME (100 μM), a nitric oxide synthase (NOS) inhibitor. The results of the study suggested that CIHH facilitated CSB through opening the K ATP channels in carotid sinus of anesthetic rats and might be one of mechanisms of CIHH keeping SABP homeostasis during acute hypoxia.
No takes yet. Share an insight, caveat, or question.
A 2012 study studied Acute hypoxia in anesthetized rats. Chronic intermittent hypobaric hypoxia (CIHH) was evaluated on Carotid sinus baroreflex (CSB). Chronic intermittent hypobaric hypoxia for 14 or 28 days markedly enhanced carotid sinus baroreflex in anesthetized rats, an effect partly abolished by a K ATP channel blocker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: